BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 19605798)

  • 1. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementing United States Pharmacopeia Chapter <1163>: Quality assurance in pharmaceutical compounding, part 4: cleaning and packaging.
    Allen LV
    Int J Pharm Compd; 2012; 16(5):405-14. PubMed ID: 23072201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing United States Pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, Part 1.
    Allen LV
    Int J Pharm Compd; 2012; 16(2):146-9. PubMed ID: 23050327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misinterpretations of United States pharmacopeia chapter <797>.
    McElhiney LF
    Int J Pharm Compd; 2012; 16(1):6-10. PubMed ID: 23050305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementing United States Pharmacopeia Chapter <1163> quality assurance in pharmaceutical compounding, Part 5: Outsourcing and responsible personnel.
    Allen LV
    Int J Pharm Compd; 2012; 16(6):490-6. PubMed ID: 23259367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 15. Commercial premixed parenteral nutrition: Is it right for your institution?
    Miller SJ
    Nutr Clin Pract; 2009; 24(4):459-69. PubMed ID: 19605800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 17. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 18. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementing United States pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, part 2: documentation and verification.
    Allen LV
    Int J Pharm Compd; 2012; 16(3):230-4. PubMed ID: 23050301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compounding vs standardized commercial parenteral nutrition product: pros and cons.
    Gervasio J
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):40S-41S. PubMed ID: 22301324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.